These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 450956)

  • 41. Studies on anisotropy of compressed powders. III. Effects of different granulation methods on anisotropy, pore size and crushing strength of tablets.
    Ando T; Yuasa H; Kanaya Y; Asahina K
    Chem Pharm Bull (Tokyo); 1983 Jun; 31(6):2045-54. PubMed ID: 6640794
    [No Abstract]   [Full Text] [Related]  

  • 42. [Preferred orientation of crystalline particles within tablets. II. Effects of shape of aspirin crystals on their orientation within tablets and breaking strength of tablets (author's transl)].
    Nakai Y; Fukuoka E; Nakagawa H
    Yakugaku Zasshi; 1978 Feb; 98(2):184-90. PubMed ID: 650392
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of temperature on diametral compression strength of delta-phenylbutazone and barbital (form II) tablets.
    Danjo K; Otsuka A
    Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):763-8. PubMed ID: 3409383
    [No Abstract]   [Full Text] [Related]  

  • 44. Internal friction of compressed pharmaceutical powders observed in terms of the die wall pressure.
    Fukuda T; Fukumori Y; Wada S; Hanyu Y
    Chem Pharm Bull (Tokyo); 1980 Feb; 28(2):393-40. PubMed ID: 7389014
    [No Abstract]   [Full Text] [Related]  

  • 45. The physical state of nafcillin sodium in frozen aqueous solutions and freeze-dried powders.
    Milton N; Nail SL
    Pharm Dev Technol; 1996 Oct; 1(3):269-77. PubMed ID: 9552309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Polymorphism and optical resolution by seeded crystallization of DL-O-acetylpantolactone (author's transl)].
    Inagaki M; Yamamoto K; Kataoka K; Akazawa O
    Yakugaku Zasshi; 1977 Feb; 97(2):151-6. PubMed ID: 558314
    [No Abstract]   [Full Text] [Related]  

  • 47. [Characteristics of barbiturate adsorption on activated charcoal].
    Luzhnikov EA; Trushin AM; Kabanov OV
    Vopr Med Khim; 1987; 33(6):64-6. PubMed ID: 3445548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study of the effect of the binding agent and compression pressure on the properties of granulates and tablets prepared by fluidization and pulverization].
    Salama AH; Kovács B; Gyarmathy M; Gyarmati L
    Acta Pharm Hung; 1976 Jan; 46(1):24-30. PubMed ID: 1258649
    [No Abstract]   [Full Text] [Related]  

  • 49. [Mixing of pharmaceutical powders with small-sized granules. II. Mixed state of small-sized granules and micronized powders (author's transl)].
    Fukuda T; Fukumori Y; Taniguchi A; Shimizu K; Nishijima T; Hanyu Y; Takeuchi Y
    Yakugaku Zasshi; 1981 Mar; 101(3):239-46. PubMed ID: 7299635
    [No Abstract]   [Full Text] [Related]  

  • 50. Contact angles of pharmaceutical powders.
    Lerk CF; Lagas M; Boelstra JP; Broersma P
    J Pharm Sci; 1977 Oct; 66(10):1480-1. PubMed ID: 925908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of complex formation on interfacial transfer rate of drugs across two liquid phases (author's transl)].
    Kiryu S; Tateyama T; Iguchi S
    Yakugaku Zasshi; 1982 Jan; 102(2):207-10. PubMed ID: 7108751
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT; Tran PH; Park JB; Lee BJ
    Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IR analysis of crystalline samples of some urea derivatives.
    Kaliszan R; Halkiewicz J
    Pol J Pharmacol Pharm; 1975; 27(5):579-87. PubMed ID: 241982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE.
    Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Eur J Pharm Biopharm; 2010 May; 75(1):71-8. PubMed ID: 19995604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of crystal form on the radial stress transmission characteristics of pharmaceutical materials.
    Summers MP; Enever RP; Carless JE
    J Pharm Pharmacol; 1976 Feb; 28(2):89-99. PubMed ID: 6687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heteroassociation of O- and N-isopropyl derivatives of barbital and phenobarbital with 9-ethyladenine.
    Gentric E; Menez JF; Lauransan J; Bardou LG; Saumagne P
    Chem Biol Interact; 1985 Jun; 54(1):117-25. PubMed ID: 4017102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thin-layer chromatographic behaviour of barbiturates under various conditions.
    Abu-Eittah R; Osman A; el-Behare A
    Analyst; 1978 Oct; 103(1231):1083-7. PubMed ID: 717792
    [No Abstract]   [Full Text] [Related]  

  • 59. [Identification of barbital, phenobarbital and ethaminal sodium by their light absorption in the IR region of the spectrum].
    Popova VI; Mynka AF; Kramarenko VF
    Farm Zh; 1977; 32(4):75-9. PubMed ID: 913559
    [No Abstract]   [Full Text] [Related]  

  • 60. [Dispersion analysis of drug forms].
    Gorbunova TV; Nazarov BV
    Farm Zh; 1975; (5):19-26. PubMed ID: 773672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.